Suetake K, Gasa S, Taki T, Chiba M, Yamaki T, Ibayashi Y, Hashi K
Department of Neurosurgery, School of Medicine, Sapporo Medical University, Japan.
Biochim Biophys Acta. 1993 Sep 29;1170(1):25-31.
A human blood group B-active glycosphingolipid, belonging to the ganglio-series, was isolated from rat glioma cell line RG2 subcutaneous isografts. The oligosaccharide structure of the glycosphingolipid was completely characterized as Gal alpha 1-3(Fuc alpha 1-2)Gal beta 1-3GalNAc beta 1-4Gal beta 1-4Glc beta 1- 1'ceramide by NMR spectrometry, negative fast atom bombardment-mass spectrometry, sequential degradation by glycosidases and methylation analysis. Human blood group B antigenicity and the activity of this glycosphingolipid were confirmed by immunostaining on thin-layer chromatography and the inhibition of hemagglutination, respectively. Although the lipid has been detected in rat granuloma, bone marrow cells, spleen, thymus, ascites hepatoma cells and gastric mucosa, this is the first report of the occurrence of the B-active lipid in glioma.
从大鼠胶质瘤细胞系RG2皮下同基因移植瘤中分离出一种属于神经节系列的具有人B血型活性的糖鞘脂。通过核磁共振光谱法、负快原子轰击质谱法、糖苷酶顺序降解法和甲基化分析,该糖鞘脂的寡糖结构被完全鉴定为Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-4Galβ1-4Glcβ1-1'神经酰胺。分别通过薄层色谱免疫染色和血凝抑制试验证实了该糖鞘脂的人B血型抗原性和活性。尽管在大鼠肉芽肿、骨髓细胞、脾脏、胸腺、腹水肝癌细胞和胃黏膜中已检测到这种脂质,但这是首次报道在胶质瘤中出现具有B活性的脂质。